Zhuhai Rundu Pharmaceutical Co., Ltd. (China)

Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern technology pharmaceutical company located in Jinwan District, Zhuhai City, Guangdong Province. It was established in 1999 and became listed on the Shenzhen Stock Exchange on January 5, 2018 (stock abbreviation: Rundu shares; stock code: 002923), with a registered capital of 239 million yuan. The company currently has over 2,000 employees. The company's main business is the research, production, and sales of chemical pharmaceutical preparations, chemical raw materials, and pharmaceutical intermediates. Its products are used in various fields, including digestive ulcers, hypertension, surgical anesthesia, antipyretic analgesics, anti-infection, and diabetes. The company has a comprehensive quality management system and has established a drug production manufacturing center in strict accordance with national GMP requirements. Its production lines, including raw materials, tablets, capsules, and intermediate preparations (microgranules), have all passed the new version of GMP certification. Some of its specialty raw material products have obtained official certifications from the World Health Organization, the European Union, Japan, and have passed on-site inspections by the US FDA.